Cavinton Forte (vinpocetin)
For treatment of: dementia, improved blood supply to the brain.Cavinton Forte nootropics
- For the treatment of internal organs: brain, eyes, ears
- Appointment: dementia, improved blood supply to the brain, post-stroke conditions, retinal circulatory disorders, Meniere's disease and syndrome
- Indications for use:
— to reduce the severity of neurological and mental symptoms in various forms of circulatory insufficiency of the brain (including conditions after an ischemic stroke, the recovery stage of a hemorrhagic stroke, the consequences of a stroke, a transient ischemic attack, vascular dementia, vertebrobasilar insufficiency, atherosclerosis of the brain vessels, post-traumatic and hypertensive encephalopathy);
— chronic vascular diseases of the eyes (lesions of the choroid and retina);
— in otorhinolaryngological practice (for the treatment of perceptual hearing loss, Meniere's disease, idiopathic tinnitus).
— acute phase of hemorrhagic stroke;
— severe IHD;
— severe arrhythmias;
— lactation (breastfeeding);
— children and adolescents under 18 years of age;
— hypersensitivity to Vinpocetine or other components.
Active substance: vinpocetin 10 mg.
Excipients: magnesium stearate - 2 mg, colloidal silicon dioxide - 2.5 mg, talc - 5 mg, lactose monohydrate - 83 mg, corn starch - 97.5 mg.